Abgenix - Crunchbase Company Profile & Funding

Q: Where is Abgenix's headquarters?

Abgenix is located in Fremont, California, United States.

Overview

Abgenix

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Abgenix

CB Rank

2072203

Abgenix is a biopharmaceutical company engaged in the discovery, development, and manufacture of human therapeutic antibodies.

Acquired by

Amgen

Founded

obfuscation

Delisted

Fremont, California, United States

51-100

www.abgenix.com/

Biotechnology

Pharmaceutical

Therapeutics

Key People

Mark Litton: Team Member
Past Role: Alder Biopharmaceuticals, Chief Business Officer and Treasurer

Details

Legal Name

Abgenix, Inc.

Operating Status

Closed

Stock Symbol

NASDAQ:ABGX

Company Type

For Profit

Founders

Raju Kucherlapati, Raymond Withy, Robert Tepper, Scott Greer

About the Company

Abgenix is a biopharmaceutical company engaged in the discovery, development, and manufacture of human therapeutic antibodies for the treatment of various disease conditions such as cancer, inflammation, and metabolic disease.

Its antibody therapeutic product candidates, which are in clinical trials include Panitumumab (ABX-EGF), a human

antibody therapeutic product candidate directed against the epidermal growth factor receptor and a candidate for the treatment of various solid tumors. It also includes ABX-10241 (ABX-PTH), which isa fully human antibody therapeutic product candidate directed against parathyroid hormone for the treatment of a secondary hyper-para-thyroidism.

Abgenix was established in 1996 and is headquartered in Fremont, California. It currently operates as a subsidiary of Amgen, Inc.